Clinical trials are the cornerstone of drug innovation in modern medicine and one of its most underutilized pathways to patient care and cutting edge therapies. Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment, and making the path to new treatment options longer.

Join us on Wednesday, May 20 for Reimagining Clinical Trials: Expanding Access by Meeting Patients Where They Are — a policy briefing and hands-on experience hosted by The Hill and Eli Lilly and Company.

Policy Briefing (3:30–4:45 PM) — Hear from lawmakers, including Rep. Raul Ruiz, MD (D-Calif.), Member, Energy & Commerce Subcommittee on Health & Co-Sponsor, Rep. Erin Houchin (R-IN), Member, Energy & Commerce Subcommittee on Health and health equity leaders on how federal regulations and legislation can be modernized to eliminate barriers to clinical trial participation.

Lilly's Mobile Research Units — Following programming, step outside to Woodrow Wilson Plaza for live tours of two medical-grade units designed to bring clinical trials directly to communities and expand access for underrepresented populations.

Happy Hour (5:00–6:00 PM) — Network with lawmakers, staffers, and key decision makers shaping the future of clinical trials over drinks on the Plaza.

Event Details
Date: Wednesday, May 20
Event starts: 3:00 p.m ET
Event concludes: 6:00 p.m ET

Location: Washington, D.C., and streaming nationwide

Recommend The Hill's newsletters to a friend: TheHill.com/signup.

400 N Capitol Street NW Suite 650, Washington, DC 20001

To ensure you receive these emails in the future, please add
thehill@email.thehill.com to your address book, contacts or safe senders list.

If you believe this has been sent to you in error, please safely unsubscribe.